| Q77804109 | 12-Hydroxyeicosatetraenoic acid upregulates P-selectin-induced tissue factor activity on monocytes |
| Q40971881 | 13-Series resolvins mediate the leukocyte-platelet actions of atorvastatin and pravastatin in inflammatory arthritis |
| Q92740891 | A Peptide Analogue of Selectin Ligands Attenuated Atherosclerosis by Inhibiting Monocyte Activation |
| Q37364649 | Absence of P-selectin delays fatty streak formation in mice |
| Q33894973 | Activated Monocytes Enhance Platelet-Driven Contraction of Blood Clots via Tissue Factor Expression |
| Q41812828 | Activated Platelets Induce an Anti-Inflammatory Response of Monocytes/Macrophages through Cross-Regulation of PGE2 and Cytokines |
| Q37786647 | Activated platelets and atherosclerosis |
| Q37353355 | Activated platelets signal chemokine synthesis by human monocytes |
| Q73109008 | Activation of human monocytes for enhanced production of interleukin 8 during transendothelial migration in vitro |
| Q44227243 | Activation of vascular cells by PAF-like lipids in oxidized LDL. |
| Q41676660 | Adhesion molecules in haemopoiesis |
| Q50526083 | Adhesive interaction between peripheral blood mononuclear cells and activated platelets in the presence of anti-human leukocyte antigen Class I alloantibody causes production of IL-1β and IL-8. |
| Q36395085 | Alloantibody induced platelet responses in transplants: potent mediators in small packages |
| Q57999487 | Anti-P-selectin antibody decreases inflammation and thrombus formation in venous thrombosis |
| Q82223456 | Anti-inflammatory influence of P-selectin on human mononuclear cells |
| Q35546879 | Arterial thrombosis for the interventional cardiologist: From adhesion molecules and coagulation factors to clinical therapeutics |
| Q37130166 | Aspirin attenuates platelet activation and immune activation in HIV-1-infected subjects on antiretroviral therapy: a pilot study |
| Q39295923 | Association of platelet activation markers with recurrence of atrial fibrillation after pulmonary vein isolation |
| Q37132791 | Beyond platelet inhibition: potential pleiotropic effects of ADP-receptor antagonists |
| Q33394357 | Beyond thrombosis: the versatile platelet in critical illness |
| Q30514562 | Cationic PAMAM dendrimers disrupt key platelet functions. |
| Q33943133 | Cell adhesion regulates gene expression at translational checkpoints in human myeloid leukocytes |
| Q45944125 | Cell type- and developmental stage-specific activation of NF-kappaB by fMet-Leu-Phe in myeloid cells. |
| Q28195775 | Changes in platelet P-selectin and in plasma C-reactive protein in acute atherosclerotic ischemic stroke treated with a loading dose of clopidogrel |
| Q73153331 | Chronic venous insufficiency is associated with increased platelet and monocyte activation and aggregation |
| Q28218124 | Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease |
| Q34019915 | Complement as a mediator of vascular inflammation and activation in allografts |
| Q30442280 | Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation |
| Q73258026 | Cross-talk between cell adhesion molecules regulates the migration velocity of neutrophils |
| Q40261154 | CysLT1 receptor engagement induces activator protein-1- and NF-kappaB-dependent IL-8 expression |
| Q74014832 | Density-dependent induction of TNF-alpha release from human monocytes by immobilized P-selectin |
| Q35877953 | Detection of circulating platelet-monocyte complexes in persons infected with human immunodeficiency virus type-1. |
| Q30829121 | Directed transport of neutrophil-derived extracellular vesicles enables platelet-mediated innate immune response |
| Q39512417 | Divergent roles of tumor necrosis factor and platelet-activating factor in endotoxin-induced release of monocyte chemoattractant protein 1 and macrophage inflammatory protein 1beta in chimpanzees |
| Q46694190 | Effects of eccentric exercise-induced muscle injury on blood levels of platelet activating factor (PAF) and other inflammatory markers |
| Q28346565 | Effects of ethanol on NF-kappaB activation, production of myeloid growth factors, and adhesive events in human endothelial cells |
| Q35043172 | Endovascular laser–tissue interactions and biological responses in relation to endovenous laser therapy |
| Q34916727 | Enterovirus 71 binding to PSGL-1 on leukocytes: VP1-145 acts as a molecular switch to control receptor interaction |
| Q34161044 | Events at the vascular wall: the molecular basis of inflammation |
| Q35039893 | Expression of COX-2 in platelet-monocyte interactions occurs via combinatorial regulation involving adhesion and cytokine signaling |
| Q41056352 | Expression of plasma platelet-activating factor acetylhydrolase is transcriptionally regulated by mediators of inflammation |
| Q90745245 | Extracorporeal Photochemotherapy: Mechanistic Insights Driving Recent Advances and Future Directions |
| Q36208502 | Genetic variant of Interleukin-18 gene is associated with the Frailty Index in the English Longitudinal Study of Ageing |
| Q30559534 | Genetic variants in platelet factor 4 modulate inflammatory and platelet activation biomarkers |
| Q35833625 | Higher levels of circulating monocyte-platelet aggregates are correlated with viremia and increased sCD163 levels in HIV-1 infection |
| Q44184963 | ITAM-based interaction of ERM proteins with Syk mediates signaling by the leukocyte adhesion receptor PSGL-1. |
| Q24291709 | Immobilized IL-8 triggers progressive activation of neutrophils rolling in vitro on P-selectin and intercellular adhesion molecule-1 |
| Q37736840 | Innate immune responses induced by lipopolysaccharide and lipoteichoic acid in primary goat mammary epithelial cells |
| Q34557811 | Integrin αDβ2 (CD11d/CD18) is expressed by human circulating and tissue myeloid leukocytes and mediates inflammatory signaling |
| Q38299411 | Integrins regulate the intracellular distribution of eukaryotic initiation factor 4E in platelets. A checkpoint for translational control. |
| Q35545087 | Intervention in endotoxin shock by sulfatide (I3SO3-GalCer) with a concomitant reduction in tumor necrosis factor alpha production |
| Q47962358 | Intestinal NF-kappaB is activated, mainly as p50 homodimers, by platelet-activating factor |
| Q53171635 | Intracoronary platelet and monocyte activation status within platelet-monocyte complexes are determinants of inflammation in ST elevation myocardial infarction1. |
| Q43279071 | Junctional adhesion molecule (JAM)-B supports lymphocyte rolling and adhesion through interaction with alpha4beta1 integrin |
| Q41986583 | Mapping the epitope of a functional P-selectin monoclonal antibody (LYP20) to a short complement-like repeat (SCR 4) domain: use of human-mouse chimaera and homologue-replacement mutagenesis |
| Q24629268 | Mechanisms involved in antibody- and complement-mediated allograft rejection |
| Q38635500 | Mechanisms of antibody-mediated acute and chronic rejection of kidney allografts |
| Q40419468 | Mechanisms of the adult respiratory distress syndrome: selectins |
| Q57574568 | Microvesicles from platelets: novel drivers of vascular inflammation |
| Q38400503 | Modulation of platelet and monocyte function by the chemokine fractalkine (CX3 CL1) in cardiovascular disease |
| Q41071075 | Molecular and cellular interactions mediating granulocyte accumulation in vivo |
| Q71815223 | Monocyte activation: rapid induction of alpha 1/beta 1 (VLA-1) integrin expression by lipopolysaccharide and interferon-gamma |
| Q46100164 | Monocyte chemoattractant protein 1 mediates glomerular macrophage infiltration in anti-GBM Ab GN. |
| Q37116502 | Monocyte-endothelial cell interactions in the development of atherosclerosis |
| Q34055659 | Monocyte-platelet interaction induces a pro-inflammatory phenotype in circulating monocytes |
| Q36274176 | New concepts of complement in allorecognition and graft rejection |
| Q33893036 | Noncovalent association of P-selectin glycoprotein ligand-1 and minimal determinants for binding to P-selectin |
| Q28348220 | Oxidized low-density lipoprotein and peroxisome-proliferator-activated receptor alpha down-regulate platelet-activating-factor receptor expression in human macrophages |
| Q73635468 | P-Selectin: Basic Aspects |
| Q40343152 | P-selectin chases a butterfly |
| Q37079911 | P-selectin cross-links PSGL-1 and enhances neutrophil adhesion to fibrinogen and ICAM-1 in a Src kinase-dependent, but GPCR-independent mechanism |
| Q39163377 | PSGL-1: A New Player in the Immune Checkpoint Landscape. |
| Q47573759 | Pathogen reduction treatment alters the immunomodulatory capacity of buffy coat-derived platelet concentrates |
| Q47887285 | Patients with venous stasis ulceration have increased monocyte-platelet aggregation |
| Q57292398 | Persistent platelet activation and apoptosis in virologically suppressed HIV-infected individuals |
| Q39787876 | Perspectives series: cell adhesion in vascular biology. Role of PSGL-1 binding to selectins in leukocyte recruitment |
| Q34549341 | Platelet - leukocyte interactions: multiple links between inflammation, blood coagulation and vascular risk. |
| Q90485368 | Platelet P-selectin initiates cross-presentation and dendritic cell differentiation in blood monocytes |
| Q38079764 | Platelet activating factor in heart failure: potential role in disease progression and novel target for therapy. |
| Q43186392 | Platelet activation in essential hypertension: implications for antiplatelet treatment |
| Q36368770 | Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18) |
| Q39403266 | Platelet, not endothelial, P-selectin expression contributes to generation of immunity in cutaneous contact hypersensitivity |
| Q36616764 | Platelet-leukocyte interactions in hemodialysis patients: culprit or bystander? |
| Q24793969 | Platelet-neutrophil conjugate formation is increased in diabetic women with cardiovascular disease |
| Q55279252 | Platelets Promote Brucella abortus Monocyte Invasion by Establishing Complexes With Monocytes. |
| Q38542454 | Platelets and Their Interactions with Other Immune Cells |
| Q37081746 | Platelets as cellular effectors of inflammation in vascular diseases |
| Q26739670 | Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases |
| Q35228522 | Platelets in early antibody-mediated rejection of renal transplants |
| Q40880206 | Platelets induce human umbilical vein endothelial cell proliferation through P-selectin |
| Q33411077 | Platelets protect from septic shock by inhibiting macrophage-dependent inflammation via the cyclooxygenase 1 signalling pathway |
| Q90352007 | Platelets: inflammatory effector cells in the conflagration of cystic fibrosis lung disease |
| Q35101184 | Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum |
| Q35633718 | Platelet–leukocyte interactions link inflammatory and thromboembolic events in ischemic stroke |
| Q38095369 | Polymorphonuclear neutrophils and instability of the atherosclerotic plaque: a causative role? |
| Q28167462 | Prospective evaluation of the relationship between platelet-leukocyte conjugate formation and recurrent myocardial ischemia in patients with acute coronary syndromes |
| Q35541858 | Role of Monocytes in Atherogenesis |
| Q74045156 | Roles and relationship of macrophages and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the ischemic and reperfused rat heart |
| Q37362400 | Selectin ligands: will the real ones please stand up? |
| Q49617012 | Selectins in cancer immunity. |
| Q36117363 | Selectins: initiators of leucocyte adhesion and signalling at the vascular wall |
| Q24675173 | Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets |
| Q40042544 | Signaling by the cysteinyl-leukotriene receptor 2. Involvement in chemokine gene transcription |
| Q30440643 | Spleen tyrosine kinase Syk is necessary for E-selectin-induced alpha(L)beta(2) integrin-mediated rolling on intercellular adhesion molecule-1. |
| Q33559676 | Stat3-dependent acute Rantes production in vascular smooth muscle cells modulates inflammation following arterial injury in mice |
| Q41478095 | Structure and function of leukocyte chemoattractant receptors |
| Q70993034 | Susceptibility to infection and altered hematopoiesis in mice deficient in both P- and E-selectins |
| Q33698336 | Synthesis of sFlt-1 by platelet-monocyte aggregates contributes to the pathogenesis of preeclampsia |
| Q40064187 | Targeting the PSGL-1 pathway for immune modulation |
| Q73667757 | Terminal complement proteins in mediating processes of accelerated graft arteriosclerosis in cardiac transplants |
| Q28137923 | The MCP/eotaxin subfamily of CC chemokines |
| Q91528926 | The P-selectin and PSGL-1 axis accelerates atherosclerosis via activation of dendritic cells by the TLR4 signaling pathway |
| Q28077024 | The Role of CC-Chemokines in the Regulation of Angiogenesis |
| Q37387115 | The combined role of P- and E-selectins in atherosclerosis |
| Q24673214 | The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1 |
| Q38373133 | The role of high-density lipoproteins in the regulation of angiogenesis. |
| Q37766875 | The role of monocytes in atherosclerotic coronary artery disease. |
| Q30437474 | The role of platelets in acute lung injury (ALI) |
| Q36677300 | The vessel wall and its interactions |
| Q33906710 | Therapeutic approaches to drug targets in atherosclerosis |
| Q47570271 | Treatment of platelets with riboflavin and ultraviolet light mediates complement activation and suppresses monocyte interleukin-12 production in whole blood |
| Q92314078 | Vascular Macrophages in Atherosclerosis |
| Q57999286 | Venous thrombosis prophylaxis by inflammatory inhibition without anticoagulation therapy |
| Q37367258 | Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking |